Overview
- The government-run portal lists cash prices for select brand-name medicines and routes users to manufacturer sites or coupons, and people on government programs are generally not eligible.
- Independent reviews find that many of the 43 branded therapies have lower-cost generic equivalents through existing discount platforms such as GoodRx or Cost Plus Drugs, challenging the site’s headline savings.
- The White House touts steep nominal cuts—often 33% to 93% off list price—with attention-grabbing examples like Wegovy around $150 per month for weight loss, though those purchases typically do not count toward deductibles.
- Reactions are mixed: GoodRx’s CEO calls it another price-comparison tool that expands reach, while advocates including FamiliesUSA and Public Citizen describe it as a limited coupon catalog, and questions have surfaced about vendor ties and transparency.
- The initiative relies on “most favored nation” terms that could shift international pricing; President Trump said some foreign prices may rise, and officials say more drugs will be added in the coming weeks.